![Kim Drapkin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kim Drapkin
Directeur/Membre du Conseil chez
CLIMB BIO, INC.
Fortune : 38 084 $ au 31/08/2026
Profil
Ms. Kimberlee C.
Drapkin, CPA, is an Independent Director at Climb Bio, Inc., an Independent Director at LENZ Therapeutics, Inc., an Independent Non-Executive Director at Imugene Ltd., an Independent Director at Acumen Pharmaceuticals, Inc. and a Member at Dana-Farber Cancer Institute, Inc. She is on the Board of Directors at Climb Bio, Inc., Lucy Therapeutics, Inc., LENZ Therapeutics, Inc., Imugene Ltd. and Acumen Pharmaceuticals, Inc. Ms. Drapkin was previously employed as a President, CEO, CFO, Director & PAO by Graphite Bio, Inc., an Independent Director by Kineta, Inc., an Independent Director by Proteostasis Therapeutics, Inc., an Independent Director by Yumanity Therapeutics, Inc., a President, Chief Financial Officer & Treasurer by Jounce Therapeutics, Inc., a Chief Financial Officer & Owner by Kcd Financial Consultants LLC, a Chief Financial Officer by EPIX Pharmaceuticals, Inc., a Chief Financial Officer by Predix Pharmaceuticals Holdings, Inc., a Finance Director by Takeda Oncology Co., a Chief Financial Officer by Avila Therapeutics, Inc., a Chief Financial Officer by Blueprint Medicines Corp., a Chief Financial Officer by Edimer Pharmaceuticals, Inc., a Chief Financial Officer by NinePoint Medical, Inc., a Chief Financial Officer by Predix Pharmaceuticals, Inc., a Principal by PricewaterhouseCoopers LLP, a Chief Financial Officer by Sesen Bio, Inc., a Chief Financial Officer & Treasurer by Voyager Therapeutics, Inc., and a Chief Financial Officer by Warp Drive Bio, Inc. She also served on the board at Yumanity, Inc. She received her undergraduate degree from Babson College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 03/06/2026 | 12 800 ( 0,02 % ) | 36 480 $ | 31/08/2026 | |
IMUGENE LTD 0,01 % | 17/12/2025 | 32 914 ( 0,01 % ) | 1 604 $ | 31/08/2026 |
-.--% | 15/06/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
CLIMB BIO, INC. -.--% | 05/06/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
Postes actifs de Kim Drapkin
| Sociétés | Poste | Début |
|---|---|---|
| ACUMEN PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/04/2022 |
| IMUGENE LIMITED | Directeur/Membre du Conseil | 21/06/2023 |
| CLIMB BIO, INC. | Directeur/Membre du Conseil | 28/03/2025 |
Lucy Therapeutics, Inc.
 Lucy Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops molecular therapies for mitochondrial diseases | Directeur/Membre du Conseil | 01/10/2024 |
Dana-Farber Cancer Institute, Inc.
 Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Provides treatment to cancer patients | Corporate Officer/Principal | - |
Anciens postes connus de Kim Drapkin
| Sociétés | Poste | Fin |
|---|---|---|
| KINETA, INC. | Directeur/Membre du Conseil | 30/06/2025 |
| LENZ THERAPEUTICS, INC. | Directeur Général | 01/03/2024 |
| JOUNCE THERAPEUTICS, INC. | President | 03/05/2023 |
Yumanity, Inc.
 Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Provides transforming drug discovery for neurodegenerative diseases services | Directeur/Membre du Conseil | 01/12/2022 |
| ░░░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Kim Drapkin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
72
Relations au 1er degré
25
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 25 |
|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
EPIX Pharmaceuticals, Inc.
 EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops pharmaceuticals | Health Technology |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, tax and business consulting services | Commercial Services |
Acumen Pharmaceuticals, Inc.
 Acumen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops medicines and diagnostics for Alzheimer's disease | Health Technology |
Predix Pharmaceuticals, Inc.
 Predix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Developes novel drugs and other related products | Health Technology |
NinePoint Medical, Inc.
 NinePoint Medical, Inc. Medical SpecialtiesHealth Technology Develops and manufactures imaging tool in evaluation of human tissue microstructure | Health Technology |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Provides treatment to cancer patients | Health Services |
Imugene Ltd.
 Imugene Ltd. BiotechnologyHealth Technology Operates as a a clinical stage immuno-oncology company | Health Technology |
Babson College
 Babson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Predix Pharmaceuticals Holdings, Inc.
 Predix Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Discovers and developes novel, highly selective, small-molecule drugs | Health Technology |
Avila Therapeutics, Inc.
 Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops covalent drugs | Health Technology |
Proteostasis Therapeutics, Inc.
 Proteostasis Therapeutics, Inc. BiotechnologyHealth Technology Develops disease-modifying therapeutics for orphan and neurodegenerative diseases | Health Technology |
Edimer Pharmaceuticals, Inc.
 Edimer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical products for improving the health and quality of life of families living with XLHED | Health Technology |
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics to treat eye diseases | Health Technology |
Blueprint Medicines Corp.
 Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
Warp Drive Bio, Inc.
 Warp Drive Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Focuses on proprietary genomic technology to discover drugs of natural origin | Commercial Services |
Jounce Therapeutics, Inc.
 Jounce Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immunotherapy company that develops therapies to treat cancer | Health Technology |
Voyager Therapeutics, Inc.
 Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
Yumanity, Inc.
Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Provides transforming drug discovery for neurodegenerative diseases services | Health Technology |
Kcd Financial Consultants LLC
 Kcd Financial Consultants LLC Investment ManagersFinance Provides financial consulting services | Finance |
Eliem Therapeutics, Inc.
 Eliem Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders | Health Technology |
Lucy Therapeutics, Inc.
Lucy Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops molecular therapies for mitochondrial diseases | Health Technology |
Graphite Bio, Inc.
 Graphite Bio, Inc. BiotechnologyHealth Technology Operates as gene editing company for DNA integrations | Health Technology |
Yumanity Therapeutics, Inc.
 Yumanity Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Kineta, Inc.
 Kineta, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
